Literature DB >> 34822003

Comparative study of royal jelly, propolis, and photobiomodulation therapies in 5-fluorouracil-related oral mucositis in rats.

Mara Luana Batista Severo1, Stéfanie Thieme2, Felipe Martins Silveira2,3, Raquel Padilha Martins Tavares4, Amanda Katarinny Goes Gonzaga5, Silvana Maria Zucolotto4, Aurigena Antunes de Araújo1, Marco Antonio Trevizani Martins2, Manoela Domingues Martins2,3, Éricka Janine Dantas da Silveira6.   

Abstract

PURPOSE: This study aimed to evaluate the effects and mechanisms of action of royal jelly (RJ) and propolis compared to photobiomodulation therapy (PBMT) in an animal model of 5-fluorouracil-related oral mucositis (OM).
METHODS: Seventy-two male Wistar rats were randomly allocated to four groups (n = 18 each): control (no treatment), PBMT (intraoral laser, 6 J/cm2), RJ, and propolis. On days 0 and 2, the animals received an injection of 5-fluorouracil (5-FU). The buccal mucosa was scratched (days 3 and 4) and the treatments were initiated on day 5. Six animals of each group were euthanized on days 8, 10, and 14. Phytochemical analysis (thin-layer chromatography, TLC) and clinical, histopathological, and immunohistochemical analysis of pS6, pAKT, and NF-κB were performed, and oxidative stress markers were also investigated.
RESULTS: TLC revealed the presence of large amounts of sucrose (Rf 0.34) in RJ and of flavonoids in propolis. Lower clinical OM scores were observed on day 8, and improved morphological data were observed on day 10 in the PBMT, RJ, and propolis groups (p < 0.05). On day 8, immunoexpression of pS6, pAKT, and NF-κB was increased compared to control. On day 14, reduced glutathione (GSH) antioxidant levels were increased in the propolis group compared to control (p < 0.05).
CONCLUSIONS: Our results showed that RJ and propolis, as well as PBMT, are effective in the treatment of OM. Considering that some patients who develop OM do not have access to PBMT, the present study demonstrated that topical application of RJ and propolis may be an important alternative for the treatment of OM.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Oral mucositis; Oxidative stress; Phytotherapics; Signaling pathways; Treatment

Mesh:

Substances:

Year:  2021        PMID: 34822003     DOI: 10.1007/s00520-021-06660-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

1.  Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).

Authors:  Marina Consuelo Vitale; Carola Modaffari; Nunzia Decembrino; Feng Xiao Zhou; Marco Zecca; Patrizia Defabianis
Journal:  Lasers Med Sci       Date:  2017-06-29       Impact factor: 3.161

2.  On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa.

Authors:  S Sonis; P W Andreotta; G Lyng
Journal:  Oral Dis       Date:  2017-01-13       Impact factor: 3.511

Review 3.  Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis.

Authors:  Stephen T Sonis; Alessandro Villa
Journal:  Expert Opin Investig Drugs       Date:  2018-01-17       Impact factor: 6.206

4.  Comparison of photobiomodulation using either an intraoral or an extraoral laser on oral mucositis induced by chemotherapy in rats.

Authors:  Stéfanie Thieme; Julia Turra Ribeiro; Bernardo Gindri Dos Santos; Renata de Almeida Zieger; Mara Luana Batista Severo; Marco Antonio Trevizani Martins; Cristiane Matté; Manoela Domingues Martins
Journal:  Support Care Cancer       Date:  2019-06-04       Impact factor: 3.603

Review 5.  Meta-analysis of randomized controlled trials of the efficacy of propolis mouthwash in cancer therapy-induced oral mucositis.

Authors:  Chen-Chen Kuo; Ruey-Hsia Wang; Hsiu-Hung Wang; Chun-Hua Li
Journal:  Support Care Cancer       Date:  2018-07-19       Impact factor: 3.603

Review 6.  An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis.

Authors:  Alessandro Villa; Stephen T Sonis
Journal:  Expert Opin Pharmacother       Date:  2020-01-28       Impact factor: 3.889

Review 7.  Exploiting PI3K/mTOR signaling to accelerate epithelial wound healing.

Authors:  R M Castilho; C H Squarize; J S Gutkind
Journal:  Oral Dis       Date:  2013-02-04       Impact factor: 3.511

8.  MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients.

Authors:  Wanessa Miranda-Silva; Wagner Gomes-Silva; Yehuda Zadik; Noam Yarom; Abdul Rahman Al-Azri; Catherine H L Hong; Anura Ariyawardana; Deborah P Saunders; M Elvira Correa; Praveen R Arany; Joanne Bowen; Karis Kin Fong Cheng; Wim J E Tissing; Paolo Bossi; Sharon Elad
Journal:  Support Care Cancer       Date:  2020-11-06       Impact factor: 3.603

Review 9.  Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.

Authors:  Stephen T Sonis
Journal:  Oral Oncol       Date:  2009-10-13       Impact factor: 5.337

10.  Laser phototherapy accelerates oral keratinocyte migration through the modulation of the mammalian target of rapamycin signaling pathway.

Authors:  Ana Carolina Amorim Pellicioli; Manoela Domingues Martins; Caroline Siviero Dillenburg; Márcia Martins Marques; Cristiane H Squarize; Rogerio M Castilho
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.